Harry Brady is Executive Director of International Vaccines Public Policy at MSD (Merck & Co.,Inc.), covering all geographies outside the United States. Harry works across all MSD inline and pipeline vaccines, supporting public policy change on investment in prevention and the introduction and optimization of immunization programs through the life course. This includes work on resilient and sustainable programs, points of vaccination, data systems and vaccine confidence. Harry sits on the Life Course Immunization Working Group at the IFPMA (International Federation of Pharmaceutical Manufacturers & Associations).